ロード中...

Efficacy for the Annual Relapse Rate after the Immunosuppressive Therapy in Patients Associated with Anti-AQP4 or Anti-MOG Antibody-Positive Optic Neuritis

PURPOSE: Although oral prednisolone is the first-line treatment for preventing recurrent optic neuritis (ON) after the completion of acute-phase treatment, especially anti-aquaporin 4 (AQP4) antibody-positive ON, and anti-myelin oligodendrocyte glycoprotein (MOG) antibody-positive ON, some patients...

詳細記述

保存先:
書誌詳細
出版年:J Ophthalmol
主要な著者: Mori, Sotaro, Kurimoto, Takuji, Murai, Yusuke, Ueda, Kaori, Sakamoto, Mari, Chihara, Norio, Yamada-Nakanishi, Yuko, Nakamura, Makoto
フォーマット: Artigo
言語:Inglês
出版事項: Hindawi 2020
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7883711/
https://ncbi.nlm.nih.gov/pubmed/33628473
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/8871146
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!